NCT07036393 Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries
| NCT ID | NCT07036393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Acupuncture |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-04-15 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was done to: * Determine the therapeutic efficacy of acupuncture as physical therapy approach in minimizing pain post upper abdominal surgeries. * Determine the therapeutic efficacy of transcutaneous electrical nerve stimulation in minimizing pain post upper abdominal surgeries. * Compare the efficacy and safety of Transcutaneous electrical nerve stimulation versus acupuncture in minimizing pain post upper abdominal surgeries.
Eligibility Criteria
Inclusion Criteria: * Patients who will have pain after upper abdominal surgery. * Adult patients will be between 20 and 45 years of age. * Both sexes will be included. * Patients have no contraindications for acupuncture or transcutaneous electrical nerve stimulation. * Patients with good compliance and fit for treatment. * This study will be applied on upper abdominal surgeries \[laparoscopic cholecystectomy, Gastrectomy\]. * Physical therapy will be used for up to 48 hours after surgery or until the time of discharge. Exclusion Criteria: * Patients with other causes of pain other than that after upper abdominal surgery. * Patients who will have any contraindication for both therapies used. * Patients with cardiovascular disease, liver, or renal disease. * Patients with malignant tumors. * Patients with metal or electronic implants. * Patients with autoimmune disease. * Pregnancy, postpartum period, breastfeeding. * Patients with recent injury in the treatment area
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07036393 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Acupuncture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07036393 currently recruiting?
Yes, NCT07036393 is actively recruiting participants. Contact the research team at samarrrsaad@gmail.com for enrollment information.
Where is the NCT07036393 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07036393 clinical trial?
NCT07036393 is sponsored by Cairo University. The trial plans to enroll 40 participants.